Trial Outcomes & Findings for Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator? (NCT NCT00443118)
NCT ID: NCT00443118
Last Updated: 2018-09-28
Results Overview
COMPLETED
PHASE3
1032 participants
2 minutes of life
2018-09-28
Participant Flow
Participant milestones
| Measure |
T-Piece
Subjects assigned to be resuscitated with T-Piece
|
SIB - With PEEP Valve
Subjects allocated to SIB with a PEEP valve attached
|
SIB-Without PEEP Valve
Self inflating bag without PEEP valve
|
|---|---|---|---|
|
Overall Study
STARTED
|
515
|
291
|
226
|
|
Overall Study
COMPLETED
|
511
|
290
|
226
|
|
Overall Study
NOT COMPLETED
|
4
|
1
|
0
|
Reasons for withdrawal
| Measure |
T-Piece
Subjects assigned to be resuscitated with T-Piece
|
SIB - With PEEP Valve
Subjects allocated to SIB with a PEEP valve attached
|
SIB-Without PEEP Valve
Self inflating bag without PEEP valve
|
|---|---|---|---|
|
Overall Study
unknown primary outcome
|
3
|
1
|
0
|
|
Overall Study
Withdrawal by Subject
|
1
|
0
|
0
|
Baseline Characteristics
Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator?
Baseline characteristics by cohort
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
Self Inflating Bag With PEEP
n=290 Participants
Subjects allocated to Self Inflating Bag with PEEP
|
Self Inflating Bag Without PEEP
n=226 Participants
Subjects allocated to Self Inflating Bag without PEEP
|
Total
n=1027 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
36 weeks
STANDARD_DEVIATION 4.1 • n=5 Participants
|
35 weeks
STANDARD_DEVIATION 5 • n=7 Participants
|
37 weeks
STANDARD_DEVIATION 4 • n=5 Participants
|
36 weeks
STANDARD_DEVIATION 4.2 • n=4 Participants
|
|
Sex: Female, Male
Female
|
208 Participants
n=5 Participants
|
117 Participants
n=7 Participants
|
101 Participants
n=5 Participants
|
426 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
303 Participants
n=5 Participants
|
173 Participants
n=7 Participants
|
125 Participants
n=5 Participants
|
601 Participants
n=4 Participants
|
|
previous deliveries
primiparous
|
220 number of participants
n=5 Participants
|
137 number of participants
n=7 Participants
|
106 number of participants
n=5 Participants
|
463 number of participants
n=4 Participants
|
|
previous deliveries
multiparous
|
291 number of participants
n=5 Participants
|
153 number of participants
n=7 Participants
|
120 number of participants
n=5 Participants
|
564 number of participants
n=4 Participants
|
|
ANTENATAL STEROIDS
YES
|
142 participants
n=5 Participants
|
84 participants
n=7 Participants
|
72 participants
n=5 Participants
|
298 participants
n=4 Participants
|
|
ANTENATAL STEROIDS
NO
|
369 participants
n=5 Participants
|
206 participants
n=7 Participants
|
154 participants
n=5 Participants
|
729 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: 2 minutes of lifePopulation: The analysis was performed by intention to treat
Outcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Proportion of Infants With a HR ≥ 100 Bpm at 2 Minutes of Life.
|
93.7 percentage of participants
|
88 percentage of participants
|
93 percentage of participants
|
SECONDARY outcome
Timeframe: 2 minutes of lifeOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Time the Newborn Takes to Reach a HR > 100 Bpm
|
1 minutes
Interval 0.5 to 1.6
|
1 minutes
Interval 0.5 to 1.8
|
1 minutes
Interval 0.5 to 1.9
|
SECONDARY outcome
Timeframe: 2 minutes of lifePopulation: the pulse-oximeter was reliable at 2 minutes in 69% of the cases in both groups.
Outcome measures
| Measure |
T-Piece
n=350 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=199 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=155 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• SpO2 Value at 2 Minutes of Life.
|
82 percentage of oxygen saturation
Standard Deviation 14
|
80 percentage of oxygen saturation
Standard Deviation 20
|
77 percentage of oxygen saturation
Standard Deviation 16
|
SECONDARY outcome
Timeframe: after 2 minutes of lifeOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Proportion of Eligible Newborns Who Entered the Study and Who Were Intubated After Failure of PPV With Mask.
|
17 percentage of participants
|
28 percentage of participants
|
23 percentage of participants
|
SECONDARY outcome
Timeframe: after 2 minutes of lifeOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Need for Chest Compression and/or Medications
|
8 participants
|
11 participants
|
6 participants
|
SECONDARY outcome
Timeframe: 1-5 minutes of lifecategorized Apgar score 1 min \<=3 and categorized Apgar score 5 min \<=5 The Apgar score is applied routinely by nurses and neonatologists to describe how vigorous the baby is at birth, it ranges from 0 to 10, with higher scores representing better outcomes.
Outcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Apgar Scores at 1 and 5 Minutes
apgar score 1 min <=3
|
153 participants
|
111 participants
|
66 participants
|
|
Apgar Scores at 1 and 5 Minutes
apgar score 5 min <=5
|
30 participants
|
24 participants
|
23 participants
|
SECONDARY outcome
Timeframe: first week of lifeOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Incidence of Neonatal Encephalopathy During First Week of Life (Classified by Sarnat)
|
21 participants
|
21 participants
|
7 participants
|
SECONDARY outcome
Timeframe: after birth and during hospitalization up to four weeksincluded pneumothorax and Pneumomediastinum
Outcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Incidence of Air Leaks
|
13 participants
|
6 participants
|
2 participants
|
SECONDARY outcome
Timeframe: during hospitalizationOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Use of Oxygen Treatment Beyond the Delivery Room
|
208 participants/
|
126 participants/
|
96 participants/
|
SECONDARY outcome
Timeframe: after birth and during hospitalization up to four weeksOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Days on Oxygen
|
13.8 days
Standard Deviation 17
|
23 days
Standard Deviation 27
|
23 days
Standard Deviation 22
|
SECONDARY outcome
Timeframe: during hospitalizationOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Need for Mechanical Ventilation or CPAP
|
116 participants
|
104 participants
|
43 participants
|
SECONDARY outcome
Timeframe: after delivery and before four weeksOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Days on Mechanical Ventilation
|
5.0 days
Standard Deviation 7.6
|
7 days
Standard Deviation 11
|
12 days
Standard Deviation 17
|
SECONDARY outcome
Timeframe: after birth and during hospitalization up to four weeksOutcome measures
| Measure |
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
Days on CPAP
|
7.83 days
Standard Deviation 11.3
|
9.6 days
Standard Deviation 11.5
|
5.2 days
Standard Deviation 6.5
|
SECONDARY outcome
Timeframe: 1 day of life and 30 days after birthPopulation: this is an analyisis among the subgroup of subjects \<32 weeks GA. this is the population at risk of this outcome. It extremely unusual intracranial hemorrhage over 32 weeks GA.
Incidence of intracranial hemorrhage grades 3-4 for preterm newborns \<32 weeks by ultrasound evaluation
Outcome measures
| Measure |
T-Piece
n=90 Participants
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP Valve
n=73 Participants
Subjects allocated to SIB with PEEP valve attached
|
SIB-Without PEEP Valve
n=34 Participants
Subjects allocated to SIB-Without PEEP valve attached
|
|---|---|---|---|
|
• Incidence of Intracranial Hemorrhage Grades 3-4 for Preterm Newborns <32 Weeks
|
10 Participants
|
1 Participants
|
3 Participants
|
Adverse Events
T-Piece
SIB - Self Inflating Bag With PEEP
SIB Without PEEP
Serious adverse events
| Measure |
T-Piece
n=511 participants at risk
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP
n=290 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag with PEEP valve
|
SIB Without PEEP
n=226 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag without PEEP valve
|
|---|---|---|---|
|
General disorders
mortality
|
2.2%
11/511 • Number of events 11
|
2.8%
8/290 • Number of events 8
|
3.1%
7/226 • Number of events 7
|
Other adverse events
| Measure |
T-Piece
n=511 participants at risk
Subjects assigned to be resuscitated with T-Piece
|
SIB - Self Inflating Bag With PEEP
n=290 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag with PEEP valve
|
SIB Without PEEP
n=226 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag without PEEP valve
|
|---|---|---|---|
|
Respiratory, thoracic and mediastinal disorders
bronchopulmonary dysplasia
|
4.1%
21/511 • Number of events 21
|
8.6%
25/290 • Number of events 25
|
8.4%
19/226 • Number of events 19
|
Additional Information
Edgardo Szyld MD, MSc
FUNDASAMIN-Fundacion para la Salud Materno Infantil
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place